CLINICAL TRIALS There is currently an open label study, evaluating the safety, tolerability, and efficacy in both males and females with androgenetic alopecia being treated with HMI-115 over a 24-week treatment period (215)
Although continued treatment is necessary for patients to benefit, uncertainty remains regarding rates of treatment discontinuation in routine clinical practice
Are you prepared for the possibility that the evaluating clinician may determine GLP-1 treatment is not appropriate for your health profile at this time
You may experience a real energy slump in the early afternoon, sometimes accompanied by irritability, brain fog or a desperate need for caffeine
GLP-1 medications improve appetite regulation and metabolic health
As GSH has a net negative charge at physiological pH, the high concentration of mGSH implies the existence of specific transport systems that work against an electrochemical gradient (Griffith and Meister, 1985